AntBio - Fueling Research, Feeding Discovery

New Products

Comprehensive assay kits for drug screening

  • Kit Solutions

    Kit Solutions

    AntBio offers mIHC kits, organoid culture kits, conventional and One-step ELISA assay kits, RNA/DNA/protein interaction kits, etc.

  • Cytokine Solutions

    Cytokine Solutions

    AntBio provides related cytokines of different cell types (organoids, stem cells, immune cells, etc.) with high purity and high activity verification

  • Target Protein Solutions

    Target Protein Solutions

    AntBio offers high performance target proteins in different research areas (antibody drugs, ADC drugs, CAR-T, small molecule drugs, etc.)

  • Loading Control

    Loading Control

    AntBio offers reliable and high-quality loading control antibodies, essential for accurate normalization in Western blotting and other protein quantification assays.

Featured Products

Essential Cytokines Special Offer

Cytokines as low as $29

15 Jul – 31 Aug, 2026

View Promotions

20% off for 5+ items

Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.

Promo Period: 1 July 2026 to 31 Dec 2026

View Promotions

New Semester Launch | Spacial Biology

Discount Code: ANT2608@20

Promotion valid from 15 Aug to 31 Oct, 2026

View Promotions
bg

About Us

AntBio - Fueling Research, Feeding Discovery

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.

About Us

50k

Happy Clients

100k

Products

70+

Doctor/Expert

20,000+

Publications

ARTICLES

Latest News

20 Aug 2026 by AntBio
Frontiers in Innovative Pharmaceutical Modalities

Frontiers in Innovative Pha...

  Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm of New Modalities: Antibody‑Drug Conjugates (ADCs), Bispecific/Multispecific Antibodies, Targeted Protein...

Frontiers in Innovative Pha...

  Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm...

View Details
Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell Receptor Signalling Cascades

Electrostatic Interactions Governing ...

This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src Family (Tyr416) recombinant rabbit mAb (S0B1068) from ANT BIO PTE....

Electrostatic Interactions Governing ...

This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src...

View Details
RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs Within TNFR1‑Mediated Signal Transduction

RIPK1 Kinase Activity (Ser166): Regul...

This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis cell‑fate decisions and RIPK1‑inhibitor pre‑clinical research. It presents Phospho‑RIP (Ser166)...

RIPK1 Kinase Activity (Ser166): Regul...

This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis...

View Details
Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic Insights for Alzheimer‑Disease‑Oriented Basic‑Research

Selective Degradation of Phosphorylat...

This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors, conformation‑selective PROTAC PRZ‑18002 mechanism and 5xFAD mouse in‑vivo experimental outcomes....

Selective Degradation of Phosphorylat...

This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors,...

View Details